RSS

Boehringer Ingelheim

Biotechnology company, Leukocare, and pharma company, Boehringer Ingelheim, have entered into a licence agreement in the field of veterinary diagnostics. more

News

Boehringer Ingelheim and Vanderbilt University have expanded their partnership to develop novel anti-cancer drugs that inhibit the myeloid cell leukaemia 1 (MCL1) protein, which is highly prevalent in many difficult to treat cancers. more

News

sanofi.jpg

360b / Shutterstock.com

In two separate press statements, Sanofi announced it has concluded its business swap with Boehringer Ingelheim, and has also closed its European vaccines joint venture with MSD (Merck & Co.). more

News

Sanofi and Boehringer Ingelheim have entered into exclusive negotiations to swap businesses more

News